BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ICON Interventional Receives CE Mark for the Nuloy® Coronary Stent System


3/9/2012 7:53:59 AM

ATLANTA, March 8, 2012 /PRNewswire/ -- Medical device company ICON Interventional Systems®, Inc. today announced it has received the CE Mark for the Nuloy Coronary Stent System, a next generation coronary stent made from a proprietary Molybdenum and Rhenium (MoRe®) alloy. The MoRe material is 99.9% pure and Nickel free with superior strength and density as compared to standard stent materials such as Cobalt Chromium and Stainless Steel. MoRe allows the fabrication of a stent platform which has extremely thin struts, superior flexibility, improved deliverability and lower profile, while not compromising radial strength or visibility.

David Kandzari, MD of the Piedmont Heart Institute in Atlanta, who has participated in the pre-clinical studies of stent deliverability offers, "My experience in the development and testing of this important new stent platform leads me to believe that it will offer the potential of a new standard in deliverability, due to the extremely thin struts, flexibility and low profile. Importantly, the stent has radiographic visibility and radial strength equivalent to much bulkier devices."

The new material allows a stent with strut thickness of 63 microns, a reduction of more than 20 percent versus the leading stents in use today. Dr. Antonio Colombo of Milan, Italy comments, "I have reviewed this new device and look forward to using it clinically, as it may offer a very strong advantage in enhanced visibility. In addition, the thin struts and excellent deliverability should lead to very favorable BMS clinical results."

ICON® is developing distribution and manufacturing options for commercial sale of the Nuloy Stent System in the European community.

About ICON Interventional Systems

ICON Interventional Systems® is an emerging medical device company developing next generation cardiovascular solutions for patients and doctors around the world. For more information visit http://www.icon-us.com.

Contact: Jack Merritt, President, 678-651-2319

ICON, the ICON Logo, Nuloy and MoRe are registered trademarks of ICON Medical Corp.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES